Clinical Trial Update: The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the metabolic effects of liraglutide on postprandial lipids, liver fat, and de novo lipogenesis in type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2022-04-12